Journal article
Clinical trial update: National Cancer Institute of Canada
Abstract
The Breast Cancer Site Group (BCSG) of the National Cancer Institute of Canada (NCIC) Clinical Trials Group (CTG) has conducted a wide variety of clinical trials focussing on large phase III trials of adjuvant chemotherapy, adjuvant hormonal therapy, and optimal delivery of adjuvant radiation therapy. The Group has also fostered, together with the NCIC CTG Investigational New Drug (IND) Program, a series of phase II and phase I/II studies which …
Authors
Pritchard K; Whelan T
Journal
Breast Cancer Research, Vol. 7, No. 2,
Publisher
Springer Nature
Publication Date
April 2005
DOI
10.1186/bcr979
ISSN
1465-5411